Adverse Events Reporting System Needs Immediate Upgrade – FDA Consultant
This article was originally published in The Tan Sheet
Executive Summary
FDA should resume an abandoned plan for software acquisition and "immediately" begin the process of upgrading Center for Drug Evaluation and Research's Adverse Events Reporting System, a consultant hired by the agency recommends in a report that is highly critical of the center's efforts to create a second-generation AERS
You may also be interested in...
FDA Needs Information Technology Strategic Plan, GAO Recommends
FDA has at least 16 projects under way to improve its information technology systems and infrastructure, but no comprehensive IT strategic plan to coordinate and manage the efforts, according to the Government Accountability Office
AERS II Would Be A Module To Fit Into Umbrella Reporting System, FDA Says
FDA now plans to develop the AERS II adverse event reporting system as a module that can eventually be incorporated into an agency-wide system
Von Eschenbach Confirmation Clears Holds At Tail-End Of Lame Duck
Andrew von Eschenbach's nomination to be FDA commissioner cleared the Senate by a comfortable 80-11 margin on Dec. 7, ending months of "holds" on the vote and opposition from both sides of the aisle